Evaluation of The Cycle SyncingⓇ Method: A 12-Week Virtual Clinical Trial
Completed · Not applicable
Conditions studied: Menstrual Cycle Disorder, Menstrual Symptoms, Hormonal Imbalance
In brief
This 12-week, 100% virtual single-group open-label trial evaluates the Cycle SyncingⓇ Method using the MyFLO app, MIRA hormonal monitoring, and continuous glucose monitoring to assess reduction in menstrual cycle symptom burden and hormonal regulation.
Key facts
- Study ID
- NCT07286136
- Run by
- FLO LIVING, LLC
- People needed
- 60
- Starts
- 2025-05-01
- Expected to finish
- 2025-10-01
- Last updated by the study team
- 2025-12-16
Who can join
Age: 22 and older, up to 42. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female participants aged 22 - 42 years
- Regular menstrual cycles
- Willingness and ability to comply with daily app usage and device protocols
- Access to a compatible smartphone and reliable internet connection
- Ability to attend a weekly virtual call with study personnel
You may not qualify if…
- Current pregnancy or breastfeeding
- Use of hormonal contraceptives or other medications known to alter menstrual cycle physiology
- Presence of significant comorbidities or chronic conditions that may interfere with study participation
- Any condition that, in the investigator's opinion, would make participation unsafe
Where it is running
- Citruslabs — Las Vegas, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.